Invitation: Live Presentation with Richard Paxman – Q1 2026
Idag, 10:00
Idag, 10:00
PAXMAN will publish its report for the first quarter of 2026 on 21 May at 07:00 CEST.
A live presentation for investors, analysts and media will be held on the same day at 10:00 CEST.
During the presentation, CEO Richard Paxman will comment on the report. The Q&A session will be moderated by Maria Karlsson Osipova. The presentation will be held in English.
The link to the presentation can be found here: https://qcnl.tv/p/HyAeq-MqrsguANQC8NPKUw
Contacts
Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se
About Us
The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. In 2025, PAXMAN AB acquired Dignitana, merging to form a stronger united company.
Today, PAXMAN’s portfolio includes both the Paxman and DigniCap systems with several thousand installations in hospitals, clinics and treatment centres worldwide, reaffirming PAXMAN as the leading global supplier of Scalp Cooling technology.
PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden). Subsidiaries of the PAXMAN Group are Paxman Coolers Limited (Huddersfield UK), Paxman Inc. (Houston, Texas US), Paxman Canada (Toronto, Ontario CA), Dignitana AB (Lund, Sweden), Dignitana Inc. (Dallas, TX US), and Dignitana S.r.l. (Milan, IT).
The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.
Attachments
Idag, 10:00
PAXMAN will publish its report for the first quarter of 2026 on 21 May at 07:00 CEST.
A live presentation for investors, analysts and media will be held on the same day at 10:00 CEST.
During the presentation, CEO Richard Paxman will comment on the report. The Q&A session will be moderated by Maria Karlsson Osipova. The presentation will be held in English.
The link to the presentation can be found here: https://qcnl.tv/p/HyAeq-MqrsguANQC8NPKUw
Contacts
Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se
About Us
The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. In 2025, PAXMAN AB acquired Dignitana, merging to form a stronger united company.
Today, PAXMAN’s portfolio includes both the Paxman and DigniCap systems with several thousand installations in hospitals, clinics and treatment centres worldwide, reaffirming PAXMAN as the leading global supplier of Scalp Cooling technology.
PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden). Subsidiaries of the PAXMAN Group are Paxman Coolers Limited (Huddersfield UK), Paxman Inc. (Houston, Texas US), Paxman Canada (Toronto, Ontario CA), Dignitana AB (Lund, Sweden), Dignitana Inc. (Dallas, TX US), and Dignitana S.r.l. (Milan, IT).
The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.
Attachments
Marknadsoron
Embracer
Aktieråd
Bomarknaden
Nibe
Evolution
Marknadsoron
Embracer
Aktieråd
Bomarknaden
Nibe
Evolution
1 DAG %
Senast
OMX Stockholm 30
0,23%
(11:48)
OMX Stockholm 30
1 DAG %
Senast
3 068,54